Search

Your search keyword '"Alnsasra H"' showing total 61 results

Search Constraints

Start Over You searched for: Author "Alnsasra H" Remove constraint Author: "Alnsasra H"
61 results on '"Alnsasra H"'

Search Results

12. Predictors and Clinical Outcomes of Vasoplegia in Patients Bridged to Heart Transplantation with Continuous Flow Left Ventricular Assist Devices

13. Cardiac magnetic resonance imaging in heart transplant recipients with biopsy-negative graft dysfunction.

14. Dapagliflozin versus sacubitril-valsartan for heart failure with mildly reduced or preserved ejection fraction.

15. Reversibility of precapillary pulmonary hypertension and outcomes after heart transplantation bridged with left ventricular assist devices: Insight from the United Network for Organ Sharing.

16. Amiodarone and pulmonary toxicity in atrial fibrillation: a nationwide Israeli study.

17. Perimyocarditis Associated with Immune Checkpoint Inhibitors: A Case Report and Review of the Literature.

18. Sex differences in ventricular arrhythmia, atrial fibrillation and atrioventricular block complicating acute myocardial infarction.

19. Dapagliflozin versus empagliflozin in patients with chronic kidney disease.

20. Depression among Patients with an Implanted Left Ventricular Assist Device: Uncovering Pathophysiological Mechanisms and Implications for Patient Care.

21. Cardiac Transplantation: Physiology and Natural History of the Transplanted Heart.

22. Effect of Dapagliflozin Versus Empagliflozin on Cardiovascular Death in Patients with Heart Failure Across the Spectrum of Ejection Fraction: Cost per Outcome Analysis.

23. Vascular Function in Continuous Flow LVADs: Implications for Clinical Practice.

24. Nonobstructive coronary atherosclerosis is associated with adverse prognosis among patients diagnosed with myocardial infarction without obstructive coronary arteries.

25. Aspirin with Low-Dose Ticagrelor or with Low-Dose Rivaroxaban for Secondary Prevention: A Cost per Outcome Analysis.

26. Characteristics, Predictors, and Outcomes of Early mTOR Inhibitor Use After Heart Transplantation: Insights From the UNOS Database.

27. Embolisation of a prosthetic mitral valve fragment during valve-in-valve transcatheter mitral valve implantation.

28. Outcomes after heart transplantation in patients with cardiac sarcoidosis.

29. Identifying patients with atrial fibrillation with a single CHA 2 DS 2 -VASC risk factor who are at higher risk of stroke.

30. Post-transplant Lymphoproliferative Disorder Following Cardiac Transplantation.

31. Incidence, Risk Factors, and Outcomes of Stroke Following Cardiac Transplantation.

34. Association of Aspirin Treatment With Cardiac Allograft Vasculopathy Progression and Adverse Outcomes After Heart Transplantation.

35. Pericardiocentesis induced right ventricular changes in patients with and without pulmonary hypertension.

36. Comparison of Outcomes with or without Beta-Blocker Therapy After Acute Myocardial Infarction in Patients Without Heart Failure or Left Ventricular Systolic Dysfunction (from the Acute Coronary Syndromes Israeli Survey [ACSIS]).

37. Effects of mTOR inhibitor-related proteinuria on progression of cardiac allograft vasculopathy and outcomes among heart transplant recipients.

38. Impact of Sirolimus as a Primary Immunosuppressant on Myocardial Fibrosis and Diastolic Function Following Heart Transplantation.

39. Rare Case of Coincident Quadricuspid Pulmonic Valve and Suprapulmonic Ridge: Multimodality Imaging.

40. Predictors and Clinical Outcomes of Vasoplegia in Patients Bridged to Heart Transplantation With Continuous-Flow Left Ventricular Assist Devices.

41. Feasibility and safety of exclusive echocardiography-guided intravenous temporary pacemaker implantation.

42. Diastolic Pulmonary Gradient as a Predictor of Right Ventricular Failure After Left Ventricular Assist Device Implantation.

44. Incidence of Malignancies in Patients Treated With Sirolimus Following Heart Transplantation.

45. Net clinical benefit of anticoagulant treatments in elderly patients with nonvalvular atrial fibrillation: Experience from the real world.

46. High-grade atrioventricular block in patients with acute myocardial infarction. Insights from a contemporary multi-center survey.

47. Contemporary Determinants of Delayed Benchmark Timelines in Acute Myocardial Infarction in Men and Women.

48. Successful treatment of ventricular fibrillation storm triggered by short-long-short sequence; time to avoid managed ventricular pacing.

49. Ethnic Diversity and Increasing Resistance Patterns of Hospitalized Community-Acquired Urinary Tract Infections in Southern Israel: A Prospective Study.

50. Swallow-induced syncope and carotid sinus hypersensitivity: Coincident or associated conditions?

Catalog

Books, media, physical & digital resources